marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Abeona Therapeutics Balance Sheet 2011-2024 | ABEO
Annual Balance Sheet Abeona Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-9.07 M | -6.59 M | -23.6 M | -10.8 M | -121 M | 11.2 M | -138 M | -69.1 M | -36.1 M | -7.12 M | -424 K | -396 K | 290 K |
Long Term Debt |
4.4 M | 5.85 M | 7.56 M | 1.43 M | - | 20 M | - | - | 4 M | 4 M | - | - | - |
Long Term Debt Current |
998 K | 1.77 M | 1.82 M | 1.71 M | 1.7 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 6.69 M | 6.25 M | 20 M | 3.06 M | 3.66 M | 10.9 M | 8.87 M | 6.43 M | 12.2 M | 9.2 M |
Total Current Liabilities |
13.4 M | 7.78 M | 16.6 M | 42 M | 38.7 M | 20.4 M | 5.61 M | 8.3 M | 1.48 M | 2.9 M | 8.96 M | 6.63 M | 12.2 M |
Total Liabilities |
49.2 M | 37.5 M | 37.2 M | 48.6 M | 45 M | 40.4 M | 8.67 M | 12 M | 12.3 M | 11.8 M | 15.4 M | 18.8 M | 21.4 M |
Deferred Revenue |
- | - | - | 296 K | 296 K | 296 K | 3.21 M | 602 K | 602 K | 602 K | 578 K | 247 K | 285 K |
Retained Earnings |
-750 M | -695 M | -656 M | -571 M | -486 M | -410 M | -360 M | -332 M | -311 M | -296 M | -266 M | -268 M | -255 M |
Total Assets |
64 M | 64.2 M | 79.6 M | 151 M | 223 M | 174 M | 179 M | 111 M | 80.1 M | 16.6 M | 613 K | 1.73 M | 3.78 M |
Cash and Cash Equivalents |
14.5 M | 14.2 M | 32.9 M | 12.6 M | 129 M | 18.8 M | 138 M | 69.1 M | 40.1 M | 11.5 M | 424 K | 396 K | 2.46 M |
Book Value |
14.8 M | 26.8 M | 42.4 M | 103 M | 178 M | 134 M | 170 M | 99.1 M | 67.7 M | 4.82 M | -14.8 M | -17.1 M | -17.6 M |
Total Shareholders Equity |
14.8 M | 26.8 M | 42.4 M | 103 M | 178 M | 134 M | 170 M | 99.1 M | 67.7 M | 4.82 M | -14.8 M | -17.1 M | -17.6 M |
All numbers in USD currency
Quarterly Balance Sheet Abeona Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
14.2 M | 16.1 M | 18.1 M | 4.4 M | 4.04 M | 4.38 M | 5.53 M | 5.85 M | 6.48 M | 6.74 M | 7.27 M | 7.56 M | 4.44 M | 4.72 M | 4.99 M | 5.26 M | 5.26 M | 5.26 M | 5.26 M | 6.25 M | 6.25 M | 6.71 M | 6.93 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.75 M | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
74.8 M | 60.8 M | 83.7 M | 49.2 M | 44 M | 44.2 M | 34.6 M | 37.5 M | 23.3 M | 24.6 M | 23.7 M | 28.2 M | 39.3 M | 46.6 M | 47 M | 48.6 M | 48.6 M | 48.6 M | 48.6 M | 45 M | 45 M | 45 M | 45 M | 40.4 M | 40.4 M | 40.4 M | 40.4 M | 8.67 M | 8.67 M | 8.67 M | 8.67 M | 12 M | 12 M | 12 M | 12 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 11.8 M | 11.8 M | 11.8 M | 11.8 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 296 K | 2.6 M | 3.21 M | 3.21 M | 3.21 M | 602 K | 602 K | 602 K | 602 K | 602 K | 602 K | 602 K | 602 K | 602 K | 602 K | 602 K | 602 K | 578 K | 578 K | 578 K | 578 K | 247 K | 247 K | 247 K | 247 K | 285 K | 285 K | 285 K | 285 K |
Retained Earnings |
-804 M | -774 M | -781 M | -750 M | -733 M | -721 M | -704 M | -695 M | 688 M | -685 M | -676 M | -656 M | -609 M | -602 M | -587 M | -571 M | -571 M | -571 M | -571 M | -486 M | -486 M | -486 M | -486 M | -410 M | -410 M | -410 M | -410 M | -360 M | -360 M | -360 M | -360 M | -332 M | -332 M | -332 M | -332 M | -311 M | -311 M | -311 M | -311 M | -296 M | -296 M | -296 M | -296 M | -266 M | -266 M | -266 M | -266 M | -268 M | -268 M | -268 M | -268 M | -255 M | -255 M | -255 M | -255 M |
Total Assets |
121 M | 134 M | 74.8 M | 64 M | 66.1 M | 53.6 M | 53.3 M | 64.2 M | 38.8 M | 44.7 M | 55.2 M | 79.6 M | 119 M | 131 M | 141 M | 151 M | 151 M | 151 M | 151 M | 223 M | 223 M | 223 M | 223 M | 174 M | 174 M | 174 M | 174 M | 179 M | 179 M | 179 M | 179 M | 111 M | 111 M | 111 M | 111 M | 80.1 M | 80.1 M | 80.1 M | 80.1 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 613 K | 613 K | 613 K | 613 K | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 3.78 M | 3.78 M | 3.78 M | 3.78 M |
Cash and Cash Equivalents |
15.7 M | 34.4 M | 17.6 M | 14.5 M | 4.71 M | 6.22 M | 4.68 M | 14.2 M | 5.73 M | 6.13 M | 20.3 M | 32.9 M | 43.8 M | 27.2 M | 14.3 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 129 M | 129 M | 129 M | 129 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 138 M | 138 M | 138 M | 138 M | 69.1 M | 69.1 M | 69.1 M | 69.1 M | 40.1 M | 40.1 M | 40.1 M | 40.1 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 424 K | 424 K | 424 K | 424 K | 396 K | 396 K | 396 K | 396 K | 2.46 M | 2.46 M | 2.46 M | 2.46 M |
Book Value |
45.8 M | 73.2 M | -8.88 M | 14.8 M | 22 M | 9.34 M | 18.7 M | 26.8 M | 15.4 M | 20.1 M | 31.4 M | 51.4 M | 79.7 M | 84.1 M | 94.4 M | 103 M | 103 M | 103 M | 103 M | 178 M | 178 M | 178 M | 178 M | 134 M | 134 M | 134 M | 134 M | 170 M | 170 M | 170 M | 170 M | 99.1 M | 99.1 M | 99.1 M | 99.1 M | 67.7 M | 67.7 M | 67.7 M | 67.7 M | 4.82 M | 4.82 M | 4.82 M | 4.82 M | -14.8 M | -14.8 M | -14.8 M | -14.8 M | -17.1 M | -17.1 M | -17.1 M | -17.1 M | -17.6 M | -17.6 M | -17.6 M | -17.6 M |
Total Shareholders Equity |
45.8 M | 73.2 M | -8.88 M | 14.8 M | 22 M | 9.34 M | 18.7 M | 26.8 M | 12.4 M | 14 M | 21.2 M | 51.4 M | 79.7 M | 84.1 M | 94.4 M | 103 M | 103 M | 103 M | 103 M | 178 M | 178 M | 178 M | 178 M | 134 M | 134 M | 134 M | 134 M | 170 M | 170 M | 170 M | 170 M | 99.1 M | 99.1 M | 99.1 M | 99.1 M | 67.7 M | 67.7 M | 67.7 M | 67.7 M | 4.82 M | 4.82 M | 4.82 M | 4.82 M | -14.8 M | -14.8 M | -14.8 M | -14.8 M | -17.1 M | -17.1 M | -17.1 M | -17.1 M | -17.6 M | -17.6 M | -17.6 M | -17.6 M |
All numbers in USD currency